Barclays
MRT

Barclays’s MedEquities Realty Trust, Inc. MRT Stock Holding History

Barclays’s Portfolio MRT Stock Details MRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-68,554
Closed -$764K – 7548
2019
Q1 		$764K Buy
68,554
+67,723
+8,150% +$733K ﹤0.01% 3697
2018
Q4 		$6K Sell
831
-12,907
-94% -$101K ﹤0.01% 6419
2018
Q3 		$133K Buy
13,738
+6,642
+94% +$70.4K ﹤0.01% 5321
2018
Q2 		$78K Sell
7,096
-8,920
-56% -$92.1K ﹤0.01% 5403
2018
Q1 		$168K Buy
16,016
+11,469
+252% +$122K ﹤0.01% 4980
2017
Q4 		$51K Buy
4,547
+3,585
+373% +$40.6K ﹤0.01% 5754
2017
Q3 		$12K Sell
962
-139
-13% -$1.65K ﹤0.01% 6074
2017
Q2 		$14K Buy
1,101
+969
+734% +$11.6K ﹤0.01% 5949
2017
Q1 		$1K Sell
132
-258
-66% -$2.88K ﹤0.01% 6696
2016
Q4 		$4K Buy
+390
New +$4.36K ﹤0.01% 6223

Barclays's MRT Position: Q2 2019 in Review

Barclays sold out of MedEquities Realty Trust, Inc. (MRT) in Q2 2019, closing a stake of 68,554 shares — an estimated $764K sold.

Barclays first reported a position in MRT in Q4 2016 and held it in 10 quarters. The position peaked at $764K in Q1 2019. 0 funds tracked by Wall St. Rank hold MRT as of Q2 2019.

  • Barclays reported no remaining MedEquities Realty Trust, Inc. position as of Q2 2019 after selling out during the quarter.
  • Barclays sold 68,554 MedEquities Realty Trust, Inc. shares in Q2 2019, an estimated $764K.
  • Barclays first reported a position in MedEquities Realty Trust, Inc. in Q4 2016 and held it in 10 quarters.
  • Barclays's MedEquities Realty Trust, Inc. position peaked at $764K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held MedEquities Realty Trust, Inc. as of Q2 2019.

Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.